All stock lists
Anaptysbio, Inc (NASDAQ:ANAB)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
48.88+0.15 (+0.32%)
Insider Score
––Not scored
ANAB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ANAB analyst forecast
ANAB analyst consensus
No analyst ratings in the last 3 months.
ANAB 12-month price target
$86.50+78.4% upsideaverage of 2 firms
$95.00High
$78.00Low
Best analysts covering ANAB
No firm covering ANAB has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ANAB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $95.00 | +73.0% | — | 2026-09-22 | |
| Wolfe Research | — | $78.00 | +38.6% | — | 2026-08-31 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.